HLB Co. Ltd

KQ:028300 Korea Biotechnology
Market Cap
$4.54 Billion
₩6.65 Trillion KRW
Market Cap Rank
#3205 Global
#61 in Korea
Share Price
₩50700.00
Change (1 day)
+4.00%
52-Week Range
₩37000.00 - ₩71900.00
All Time High
₩120800.00
About

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, inclu… Read more

HLB Co. Ltd (028300) - Total Assets

Latest total assets as of September 2025: ₩703.48 Billion KRW

Based on the latest financial reports, HLB Co. Ltd (028300) holds total assets worth ₩703.48 Billion KRW as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

HLB Co. Ltd - Total Assets Trend (2005–2024)

This chart illustrates how HLB Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

HLB Co. Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

HLB Co. Ltd's total assets of ₩703.48 Billion consist of 19.4% current assets and 80.6% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩93.05 Billion 10.5%
Accounts Receivable ₩9.01 Billion 1.0%
Inventory ₩9.69 Billion 1.1%
Property, Plant & Equipment ₩83.77 Billion 9.4%
Intangible Assets ₩272.79 Billion 30.7%
Goodwill ₩39.64 Billion 4.5%

Asset Composition Trend (2005–2024)

This chart illustrates how HLB Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: HLB Co. Ltd's current assets represent 19.4% of total assets in 2024, an increase from 0.0% in 2005.
  • Cash Position: Cash and equivalents constituted 10.5% of total assets in 2024, down from 17.3% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 0.0% in 2005.
  • Asset Diversification: The largest asset category is intangible assets at 30.7% of total assets.

HLB Co. Ltd Competitors by Total Assets

Key competitors of HLB Co. Ltd based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

HLB Co. Ltd - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.06 - 0.21

Lower asset utilization - HLB Co. Ltd generates 0.08x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -24.95% - 8.34%

Negative ROA - HLB Co. Ltd is currently not profitable relative to its asset base.

HLB Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.65 1.18 2.57
Quick Ratio 0.57 1.06 2.52
Cash Ratio 0.00 0.58 0.00
Working Capital ₩-63.67 Billion ₩ 26.95 Billion ₩ 153.55 Billion

HLB Co. Ltd - Advanced Valuation Insights

This section examines the relationship between HLB Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 17.04
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 18.1%
Total Assets ₩887.42 Billion
Market Capitalization $4.11 Billion USD

Valuation Analysis

Below Book Valuation: The market values HLB Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: HLB Co. Ltd's assets grew by 18.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for HLB Co. Ltd (2005–2024)

The table below shows the annual total assets of HLB Co. Ltd from 2005 to 2024.

Year Total Assets Change
2024-12-31 ₩887.42 Billion +18.05%
2023-12-31 ₩751.72 Billion -22.28%
2022-12-31 ₩967.27 Billion +30.06%
2021-12-31 ₩743.69 Billion +5.27%
2020-12-31 ₩706.48 Billion +94.83%
2019-12-31 ₩362.61 Billion +19.26%
2018-12-31 ₩304.04 Billion +61.56%
2017-12-31 ₩188.19 Billion +0.80%
2016-12-31 ₩186.71 Billion +0.83%
2015-12-31 ₩185.17 Billion +241.32%
2014-12-31 ₩54.25 Billion +50.27%
2013-12-31 ₩36.10 Billion -5.60%
2012-12-31 ₩38.24 Billion -29.51%
2011-12-31 ₩54.25 Billion -6.64%
2010-12-31 ₩58.11 Billion -28.68%
2009-12-31 ₩81.48 Billion +16.90%
2008-12-31 ₩69.70 Billion +45.04%
2007-12-31 ₩48.05 Billion +48.89%
2006-12-31 ₩32.27 Billion +30.35%
2005-12-31 ₩24.76 Billion --